MYL4 and hypertrophic cardiomyopathy: Interestingly, in patients with dilated and hypertrophic cardiomyopathy, a significant increase in MYL4 was observed (Morano et al., 1997; Ritter et al., 1999), and it was hypothesized that this upregulation may be part of a compensatory mechanism.